B. Metzler Seel. Sohn & Co. Ag Vertex Pharmaceuticals Inc Transaction History

B. Metzler Seel. Sohn & Co. Ag

$10 Billion
Q3 2024

A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 39,993 shares of VRTX stock, worth $18.7 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

39,993

Previous 35,235 13.5%

Holding current value

$18.7 Million

Previous $16.5 Million 12.62%

% of portfolio

0.19%

Previous 0.17%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$460.0 - $505.78 $2.19 Million - $2.41 Million	4,758 Added 13.5%	39,993 $18.6 Million
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $7.74 Million - $9.56 Million	19,699 Added 126.8%	35,235 $16.5 Million
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $26,092 - $28,549	-64 Reduced 0.41%	15,536 $6.49 Million
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $200,998 - $240,658	-586 Reduced 3.62%	15,600 $6.35 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $198,173 - $212,401	586 Added 3.76%	16,186 $5.63 Million
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $746,118 - $835,082	-2,373 Reduced 13.2%	15,600 $5.49 Million
Q1 2023 May 10, 2023	SELL	$283.23 - $323.1 $658,792 - $751,530	-2,326 Reduced 11.46%	17,973 $5.66 Million
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $1.06 Million - $1.19 Million	-3,695 Reduced 15.4%	20,299 $5.86 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $207,015 - $230,980	756 Added 3.25%	23,994 $6.95 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $34,774 - $43,297	-148 Reduced 0.63%	23,238 $6.55 Million
Q1 2022 May 10, 2022	BUY	$221.42 - $260.97 $15,720 - $18,528	71 Added 0.3%	23,386 $6.1 Million
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $4.13 Million - $5.21 Million	23,315 New	23,315 $5.19 Million

Others Institutions Holding VRTX

# of Institutions

1,722

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.

Account

B. Metzler Seel. Sohn & Co. Ag Vertex Pharmaceuticals Inc Transaction History